Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Melanoma/Skin Cancer
  •  Sarcomas
  •  Pancreatic Cancer
  •  Cervical Cancer
  •  Urological Cancers
  •  Endoscopy Methods
  •  Endometrial Cancer
  •  Kidney Cancer


Citation: Clin Oncol. 2019;4(1):1670.DOI: 10.25107/2474-1663.1670

Mucinous Cystadenocarcinoma of the Breast: A Case Report

Victor E Valdespino, Israel Lopez Matamoros, Miguel Lopez Valle, Mara Mayorga Rangel, Hilda Mendoza Ramon and Victor Valdespino Gomez

Department of Oncology and Gynecology, Luis Castelazo Ayala, Mexico
Department of Pathology, Luis Castelazo Ayala, Mexico
Department of Surgical Oncology, Luis Castelazo Ayala, Mexico

*Correspondance to: Victor E Valdespino 

 PDF  Full Text Case Report | Open Access


The WHO categorizes the breast tumors in 21 distinct histological types based on cell morphology and architecture. A widely accepted fact that the aggressive nature of the breast cancer can be determined by its histological type, grade, nodal status, and metastasis holds the ground even in the era of Immunohistochemistry (IHC) and molecular.
An extremely rare variant of primary breast carcinoma belongs to the family of mucin‑producing carcinoma sharing the same histology as the mucinous cystadenocarcinoma of the ovary and pancreas. Similar to our case, most of these tumors are reported in postmenopausal females aged between 47 and 96 years. Due to the rarity of these tumors, there is an extreme paucity of literature on this topic. Most of the literature available is in the form of case reports. We show a 68 years old patient with a breast tumor, with a starting biopsy papillary proliferation disease, a tumorectomy reported phyllodes with mucinous cystadenocarcinoma with narrow border after that, the patient was programmed a radical modify mastectomy with nodal axillary dissection. She is alive without adjuvant treatment afterward for 21 months.


Cite the Article:

Valdespino VE, Matamoros IL, Valle ML, Rangel MM, Ramon HM, Gomez VV. Mucinous Cystadenocarcinoma of the Breast: A Case Report. Clin Oncol. 2019;4:1670.

Search Our Journal

Journal Indexed In

Articles in PubMed

LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
NMR Metabolomics in Ionizing Radiation
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Primary Uveal Lymphoma: Report of Three Cases with Histopathology Proven
 Abstract  PDF  Full Text
Pediatric Cancer Predisposition Documentation Tool - Standardized Reporting Form for Children and Adolescents with Suspected Cancer Predisposition Syndrome
 Abstract  PDF  Full Text
View More...